Drangel Rose

Drangel Rose currently serves as a Clinical Oncology Data Analyst at ConcertAI, where he plays a pivotal role in advancing oncology research through meticulous data abstraction and curation from Electronic Medical Records (EMR) and Electronic Health Records (EHR). His expertise lies in extracting high-quality, real-world data (RWE) to support clinical trials, observational studies, and real-world evidence generation, which are critical for informing treatment strategies and improving patient outcomes in oncology. In his role, Drangel is responsible for reviewing patient records, screening for eligibility, and ensuring the accuracy and integrity of clinical data, leveraging his strong analytical skills and logical reasoning to identify relevant data points efficiently.

At ConcertAI, Drangel is actively involved in key projects that utilize real-world evidence to assess treatment effectiveness, safety profiles, and healthcare utilization patterns among cancer patients. His work supports the development of robust datasets that underpin regulatory decision-making and healthcare policy. With a background in dentistry and advanced training in clinical research and pharmacovigilance, he brings a comprehensive understanding of clinical data management, clinical trials, and pharmacovigilance practices. His proficiency in project management ensures seamless coordination across multidisciplinary teams, facilitating timely delivery of high-quality insights.

Drangel’s expertise extends to clinical data review, electronic data capture (EDC), and research, making him a valuable contributor to ConcertAI’s mission of transforming oncology care through data-driven insights. His dedication to leveraging real-world data and his keen attention to detail help accelerate the development of innovative therapies and personalized treatment approaches, ultimately contributing to improved patient outcomes in the oncology landscape.